Bi-layered neural interface with nerve-facing drug eluting structure
A implantable neural electrode assembly is described. The implantable neural electrode assembly includes a plurality of open-ended rings alternatingly connected to a spine. An inner layer of the open-ended rings is formed from a drug-loaded material (e.g., silicone that has been loaded with a steroid) and an outer layer is formed from a drug-free material. One or more electrode assemblies are connected to the inner layer and oriented towards a center of a cylinder defined by the plurality of open-ended rings.
1. An electrode assembly, comprising:
a spine to support a lead conductor; and
a first open-ended ring comprising a first connected end connected to the spine and a first open end, the first open-ended ring comprising:
a first layer defining an interior surface of the first open-ended ring, the first layer formed from a drug-loaded silicone, the interior surface oriented toward a center of the first open-ended ring;
a first electrode fixedly supported by the first layer and disposed at the interior surface, the first electrode configured to electrically connect to the lead conductor; and
a second layer defining an exterior surface of the first open-ended ring, the second layer formed from a drug-free silicone, the exterior surface oriented away from the center of the first open-ended ring.
2. The electrode assembly of claim 1 , wherein the first layer is coupled to the second layer.
3. The electrode assembly of claim 1 , wherein the drug-loaded silicone is loaded with an anti-inflammatory steroid.
4. The electrode assembly of claim 3 , wherein the anti-inflammatory steroid is Dexamethasone Acetate (DXA).
5. The electrode assembly of claim 1 , further comprising a second open-ended ring comprising a second connected end connected to the spine and a second open end, the second open-ended ring comprising:
a third layer defining an interior surface of the second open-ended ring, the third layer formed from the drug-loaded silicone;
a second electrode fixedly supported by the third layer and disposed at the interior surface of the second open-ended ring; and
a fourth layer defining an exterior surface of the second open-ended ring, the fourth layer formed from the drug-free silicone.
6. The electrode assembly of claim 5 , further comprising a third open-ended ring comprising a third connected end connected to the spine and a third open end, the third open-ended ring formed from the drug-free silicone.
7. The electrode assembly of claim 6 , wherein the first open-ended ring is positioned distally relative to the second open-ended ring, and the third open-ended ring is positioned between the first open-ended ring and the second open-ended ring.
8. The electrode assembly of claim 1 further comprising the lead conductor.
9. The electrode assembly of claim 8 , wherein the first open-ended ring further comprises a second electrode fixedly supported by the first layer and disposed at the interior surface, the second electrode electrically connected to the lead conductor.
10. The electrode assembly of claim 8 , wherein the first electrode comprises an electrode surface defined at a first side and one or more electrode leads positioned on a second opposite side, and wherein the electrode surface is oriented toward a center of the first open-ended ring and the first electrode is electrically connected to the lead conductor via the one or more electrode leads.
11. The electrode assembly of claim 1 , wherein the second layer comprises an overmold.
12. The electrode assembly of claim 11 , wherein the overmold forms the spine and encases the lead conductor.
13. The electrode assembly of claim 1 , wherein the first layer comprises a first side and a second side, the interior surface is defined at the first side of the first layer, and the second layer encases the second side of the first layer.
14. The electrode assembly of claim 1 , wherein a window is formed in the first layer and the first electrode is fixedly supported within the window.
15. The electrode assembly of claim 1 , wherein, when the electrode assembly is implanted in tissue of a subject, the drug-loaded silicone releases drugs through the interior surface without releasing the drugs through the exterior surface.
16. The electrode assembly of claim 15 , wherein releasing the drugs through the interior surface prevents fibrosis in the tissue of the subject.
17. The electrode assembly of claim 1 , wherein the spine and the first open-ended ring are sized and configured for implantation in tissue of a subject.